IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TINCANI, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.642
EU - Europa 20.685
AS - Asia 18.143
SA - Sud America 3.792
Continente sconosciuto - Info sul continente non disponibili 910
AF - Africa 592
OC - Oceania 73
Totale 81.837
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.977
CN - Cina 6.348
SG - Singapore 5.518
IT - Italia 5.243
UA - Ucraina 3.998
DE - Germania 3.407
BR - Brasile 3.119
HK - Hong Kong 2.396
PL - Polonia 1.835
FR - Francia 1.262
VN - Vietnam 1.240
FI - Finlandia 1.167
RU - Federazione Russa 1.021
GB - Regno Unito 990
TR - Turchia 714
IE - Irlanda 698
BD - Bangladesh 521
IN - India 473
CA - Canada 312
AR - Argentina 265
SE - Svezia 226
NL - Olanda 200
MX - Messico 190
ES - Italia 167
IQ - Iraq 138
ZA - Sudafrica 131
NG - Nigeria 129
ID - Indonesia 117
EC - Ecuador 105
JP - Giappone 104
MA - Marocco 104
CO - Colombia 87
PK - Pakistan 67
AT - Austria 65
AU - Australia 61
SA - Arabia Saudita 55
VE - Venezuela 55
UZ - Uzbekistan 53
PY - Paraguay 45
BE - Belgio 44
CL - Cile 44
EG - Egitto 44
IL - Israele 42
CZ - Repubblica Ceca 41
EU - Europa 41
JO - Giordania 36
RO - Romania 36
CH - Svizzera 35
KE - Kenya 35
TN - Tunisia 35
DZ - Algeria 34
UY - Uruguay 33
JM - Giamaica 31
LT - Lituania 31
KZ - Kazakistan 29
AL - Albania 26
NP - Nepal 26
PH - Filippine 26
EE - Estonia 25
LB - Libano 25
AE - Emirati Arabi Uniti 23
CR - Costa Rica 23
GR - Grecia 21
KR - Corea 21
TH - Thailandia 21
TW - Taiwan 21
IR - Iran 20
PE - Perù 20
AZ - Azerbaigian 19
HN - Honduras 18
DK - Danimarca 17
PT - Portogallo 17
ET - Etiopia 16
HU - Ungheria 16
TT - Trinidad e Tobago 16
BO - Bolivia 15
DO - Repubblica Dominicana 15
SK - Slovacchia (Repubblica Slovacca) 15
SN - Senegal 15
MU - Mauritius 12
MK - Macedonia 11
BG - Bulgaria 10
SV - El Salvador 10
LY - Libia 9
MY - Malesia 9
NO - Norvegia 9
PS - Palestinian Territory 9
RS - Serbia 9
GT - Guatemala 8
KG - Kirghizistan 8
LU - Lussemburgo 8
LV - Lettonia 8
PA - Panama 8
BH - Bahrain 7
BY - Bielorussia 7
GE - Georgia 7
KW - Kuwait 7
NI - Nicaragua 6
NZ - Nuova Zelanda 6
OM - Oman 6
Totale 80.845
Salva come PNG Salva come JPEG
Città #
Fairfield 4.277
Woodbridge 3.986
Singapore 2.903
Ashburn 2.833
Jacksonville 2.819
Houston 2.756
Hong Kong 2.368
Warsaw 1.808
Ann Arbor 1.736
Seattle 1.641
Cambridge 1.640
Wilmington 1.517
The Dalles 1.422
Beijing 1.267
Princeton 1.214
San Jose 1.122
Nanjing 932
Chandler 752
New York 752
Dublin 633
Helsinki 624
Istanbul 572
Los Angeles 566
Lauterbourg 552
Milan 509
Columbus 481
Ho Chi Minh City 421
Nanchang 353
Council Bluffs 348
Buffalo 324
Des Moines 304
São Paulo 288
Rome 267
Moscow 263
Hanoi 261
Shenyang 251
Munich 246
Dallas 241
San Diego 235
Changsha 233
Hebei 230
Brescia 225
Redondo Beach 191
Tianjin 173
Shanghai 166
Chicago 154
London 149
Jiaxing 148
San Francisco 147
Santa Clara 145
Lancaster 138
Jinan 133
Florence 129
Abuja 124
Verona 124
Rio de Janeiro 103
Hangzhou 102
Nürnberg 102
Orem 96
Kunming 88
Tokyo 86
Chennai 84
Nuremberg 79
Turku 79
Toronto 78
Bologna 74
Guangzhou 74
Turin 72
Brooklyn 70
Johannesburg 70
Frankfurt am Main 69
Phoenix 69
Montreal 65
Belo Horizonte 62
Mexico City 62
Trieste 61
Dearborn 60
Zhengzhou 59
Boardman 58
Atlanta 57
Baghdad 57
Porto Alegre 54
Amsterdam 53
Dhaka 51
Lanzhou 51
Mumbai 51
Ningbo 50
Brasília 49
Curitiba 49
Kocaeli 49
Paris 49
Haiphong 48
Bergamo 47
Da Nang 47
Dong Ket 47
Poplar 46
Tashkent 46
Denver 44
Genoa 44
Manchester 44
Totale 50.948
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.393
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.856
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). 1.487
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 343
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 322
Abatacept reduces levels of switched memory B cells, autoantobodies, and immunoglobulins in patients with Rheumatoid Arthritis 321
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 307
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. 300
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients. 298
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation 257
Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction? 251
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 247
Preface. What's New in Autoimmunity: New Autoantibodies, New Therapies, New Diseases 244
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 238
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 237
Long-term outcome of children of rheumatic disease patients 234
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. 231
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 224
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 221
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 220
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 213
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 211
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 210
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome 208
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 205
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends 201
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 198
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 197
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 197
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 196
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 194
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage 194
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 192
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 192
New acquirements on an old molecule: type I interferon. 191
Effect of short-term treatment with lercanidipine on circulating endothelial progenitor cells and structural alterations in retinal arterioles 191
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 191
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 188
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 188
Failure of intravenous immunoglobulin to prevent congenital heartblock: Findings of a multicenter, prospective, observational study 187
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 187
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. 186
Typing TREX1 Gene In Patients With Systemic Lupus Erythematosus. 185
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 185
Anti-phospholipid antibodies 183
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 182
Children born to SLE and APS mothers 182
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 182
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 181
Management of thrombotic and obstetric antiphospholipid syndrome: A systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults 180
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 179
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 178
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 178
A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus 177
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 176
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 174
Antiphospholipid antibodies mediate autoimmunity against dying cells. 173
Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension 173
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 173
25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. 172
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 171
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 171
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 171
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 170
Effetto del trattamento a breve termine con lercanidipina sulle cellule progenitrici endoteliali circolanti e sulle alterazioni strutturali delle arteriole retiniche 170
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 170
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 169
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 168
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 168
Inflammatory molecules: A target for treatment of systemic autoimmune diseases. 167
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 167
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 166
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 165
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 164
Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I 163
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 163
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 162
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 160
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study 160
Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease'. 159
Pregnancy complications of the antiphospholipid syndrome 158
Autoimmune polyendocrine Syndromes 157
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 157
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 156
Effect of pregnancy on serum cytokines in SLE patients. 155
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 155
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 155
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 155
Long-term outcome of children born from mothers with autoimmune diseases 155
Forum interdisciplinare per la ricerca delle malattie autoimmuni (FIRMA) study group. Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. 154
Aicardi Goutieres Syndrome: New Insights on a Novel Set of Inborn Errors of Immunity 154
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 154
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 153
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 153
V meeting of the European forum on antiphospholipid antibodies. 152
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 152
State of the art: Reproduction and pregnancy in rheumatic diseases. 152
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D 152
Neuropsychological development of children born to patients with systemic lupus erythematosus 151
Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? 151
Totale 24.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 381.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 381.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.945 0 978 159 312 145 300 317 393 289 556 468 1.028
2022/20233.583 701 46 82 180 281 995 41 288 517 54 206 192
2023/20244.334 235 124 327 346 191 637 156 180 1.244 108 90 696
2024/202510.258 141 131 102 1.184 1.088 918 934 405 866 1.148 2.099 1.242
2025/202619.700 1.792 2.881 1.666 3.190 1.738 1.194 2.712 711 1.112 1.603 695 406
2026/20271.614 1.062 552 0 0 0 0 0 0 0 0 0 0
Totale 81.837